Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amar Elezović"'
Autor:
Jasmina Hadžiabdić, Selma Špirtović-Halilović, Amar Osmanović, Lejla Zahirović, Amar Elezović
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 58 (2022)
Abstract The aim of the present study is to improve the solubility and antimicrobial activity of 3-(3-(2-chlorophenyl)prop-2-enoyl)-4-hydroxycoumarin by formulating its inclusion complexes with 2-hydroxypropyl-β-cyclodextrin in solution and in solid
Externí odkaz:
https://doaj.org/article/5f1424f9d77749d7b0af1983ca046bbe
Autor:
Alisa Elezović, Amina Marić, Amila Biščević, Jasmina Hadžiabdić, Selma Škrbo, Selma Špirtović-Halilović, Ognjenka Rahić, Edina Vranić, Amar Elezović
Publikováno v:
ADMET and DMPK, Vol 9, Iss 1 (2020)
The kinetics of passive transport of ketoprofen and metformin, as model substances for high and low permeability, respectively, across the artificial membrane under the influence of the pH of donor solution was investigated. There was an upward trend
Externí odkaz:
https://doaj.org/article/e24a529150f54381829629b4d4f24648
Publikováno v:
Acta Poloniae Pharmaceutica - Drug Research. 77:43-56
Autor:
Amar Elezović, Alisa Elezović, Aida Kulo, Tanja Dujic, Sandra Cvijić, Ewan R. Pearson, Selma Imamovic Kadric, Tamer Bego, Maja Malenica
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 367, p 367 (2021)
Volume 11
Issue 5
Journal of Personalized Medicine, Vol 11, Iss 367, p 367 (2021)
The antidiabetic drug gliclazide is partly metabolized by CYP2C19, the main enzyme involved in omeprazole metabolism. The aim of the study was to explore the interaction between omeprazole and gliclazide in relation to CYP2C19 phenotype using physiol
Publikováno v:
IFMBE Proceedings ISBN: 9783030739089
Proceedings of the International Conference on Medical and Biological Engineering 2021 (Cmbebih 2021
Proceedings of the International Conference on Medical and Biological Engineering 2021 (Cmbebih 2021
In last two decades in silico biopharmaceutics modelling has become increasingly important in all stages of drug development. One of the widely used pharmacokinetic modelling software is Gastro Plus that, with its additional dosage routes modules, en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03726bf3ac68eed50c5dedf2bf19ab79
https://doi.org/10.1007/978-3-030-73909-6_74
https://doi.org/10.1007/978-3-030-73909-6_74
Autor:
Tanja Dujic, Sandra Cvijic, Amar Elezovic, Tamer Bego, Selma Imamovic Kadric, Maja Malenica, Alisa Elezovic, Ewan R. Pearson, Aida Kulo
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 5, p 367 (2021)
The antidiabetic drug gliclazide is partly metabolized by CYP2C19, the main enzyme involved in omeprazole metabolism. The aim of the study was to explore the interaction between omeprazole and gliclazide in relation to CYP2C19 phenotype using physiol
Externí odkaz:
https://doaj.org/article/43967b59cc724390a6810ee03ac106b2